Business Description
RAMM Pharma Corp
NAICS : 325412
SIC : 3741
ISIN : CA75150G1046
Share Class Description:
XCNQ:RAMM: Ordinary SharesDescription
RAMM Pharma Corp is primarily engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. The group generates revenue primarily from the sale of medical devices and consumables, the sale of pharmaceutical products, and sale of cosmetics. Geographically, it derives a majority of revenue from Uruguay.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.08 | |||||
| Equity-to-Asset | 0.93 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -2.72 | |||||
| Beneish M-Score | -2.41 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -8 | |||||
| 3-Year EBITDA Growth Rate | 9 | |||||
| 3-Year EPS without NRI Growth Rate | 7.4 | |||||
| 3-Year FCF Growth Rate | 8.3 | |||||
| 3-Year Book Growth Rate | -11.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 99.87 | |||||
| 9-Day RSI | 97.23 | |||||
| 14-Day RSI | 90.13 | |||||
| 6-1 Month Momentum % | -60 | |||||
| 12-1 Month Momentum % | -86.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.47 | |||||
| Quick Ratio | 1.96 | |||||
| Cash Ratio | 0.85 | |||||
| Days Inventory | 283.93 | |||||
| Days Sales Outstanding | 58.74 | |||||
| Days Payable | 78.18 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.2 | |||||
| Shareholder Yield % | 11.38 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 11.99 | |||||
| Operating Margin % | -152.36 | |||||
| Net Margin % | -198.55 | |||||
| FCF Margin % | -108.37 | |||||
| ROE % | -31.21 | |||||
| ROA % | -28.71 | |||||
| ROIC % | -27.42 | |||||
| ROC (Joel Greenblatt) % | -41.86 | |||||
| ROCE % | -30.85 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.53 | |||||
| PB Ratio | 0.09 | |||||
| Price-to-Tangible-Book | 0.1 | |||||
| EV-to-EBIT | -0.13 | |||||
| EV-to-EBITDA | -0.15 | |||||
| EV-to-Revenue | 0.25 | |||||
| EV-to-FCF | -0.23 | |||||
| Price-to-Net-Current-Asset-Value | 0.5 | |||||
| Earnings Yield (Greenblatt) % | -769.23 | |||||
| FCF Yield % | -202.81 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
RAMM Pharma Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | 4.469 | ||
| EPS (TTM) (C$) | -0.074 | ||
| Beta | -1.26 | ||
| Volatility % | 161.73 | ||
| 14-Day RSI | 90.13 | ||
| 14-Day ATR (C$) | 0.001307 | ||
| 20-Day SMA (C$) | 0.01175 | ||
| 12-1 Month Momentum % | -86.67 | ||
| 52-Week Range (C$) | 0.01 - 0.08 | ||
| Shares Outstanding (Mil) | 119.39 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
RAMM Pharma Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
RAMM Pharma Corp Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
RAMM Pharma Corp Frequently Asked Questions
What is RAMM Pharma Corp(XCNQ:RAMM)'s stock price today?
The current price of XCNQ:RAMM is C$0.02. The 52 week high of XCNQ:RAMM is C$0.08 and 52 week low is C$0.01.
When is next earnings date of RAMM Pharma Corp(XCNQ:RAMM)?
The next earnings date of RAMM Pharma Corp(XCNQ:RAMM) is .
Does RAMM Pharma Corp(XCNQ:RAMM) pay dividends? If so, how much?
RAMM Pharma Corp(XCNQ:RAMM) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers